ArticleFrontiers in neurology2024
Evaluating the reliability and validity of a Chinese version of the performance-oriented mobility assessment among patients with chronic stroke.
Article in Frontiers in neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The Performance-Oriented Mobility Assessment (POMA) is a reliable instrument for evaluating the mobility (balance and gait) of patients with chronic stroke to manage their risk of falling; however, it has not been validated among Chinese patients with stroke. This study aimed to evaluate the reliability and validity of the Chinese POMA in patients with stroke. Methods: The POMA was applied to volunteer patients with stroke from the Shanghai MCC Hospital. The patients underwent the Chinese POMA, Berg balance scale (BBS), and timed up and go (TUG) tests on the first day of inpatient treatment. The same physician repeated the tests the next day to assess test-retest reliability, and upon the patient's discharge from the inpatient department, two different physicians measured inter-rater reliability. Results: The study involved 76 patients with stroke (age: 62.04 ± 9.76 years; 34.2% female). The results showed that the Chinese POMA had good overall internal consistency ( Conclusion: The Chinese POMA showed acceptable reliability and validity for evaluating mobility (balance and gait) in Chinese patients with stroke in terms of their risk of falling. However, further evaluation of the two-factor model (balance and gait) is required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.